These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29281872)

  • 1. Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
    Kim JH; Shin SJ; Heo SJ; Choe EA; Kim CG; Jung M; Keum KC; Yoon JS; Lee SC; Shin SJ
    Cancer Res Treat; 2018 Oct; 50(4):1238-1251. PubMed ID: 29281872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA; Bourne TD; Murali R
    Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing.
    Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE
    Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
    Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
    van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
    Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
    Glasgow BJ; McCannel TA
    Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
    Pan H; Lu L; Cui J; Yang Y; Wang Z; Fan X
    Aging (Albany NY); 2020 Jan; 12(2):1446-1464. PubMed ID: 31954372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of patients with recurrent uveal melanoma after treatment with radiation therapy.
    Lane AM; Hartley C; Go AK; Wu F; Gragoudas ES; Kim IK
    Br J Ophthalmol; 2024 May; 108(5):729-734. PubMed ID: 37402487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival.
    Rodrigues M; Ait Rais K; Salviat F; Algret N; Simaga F; Barnhill R; Gardrat S; Servois V; Mariani P; Piperno-Neumann S; Roman-Roman S; Delattre O; Cassoux N; Savignoni A; Stern MH; Pierron G
    JAMA Ophthalmol; 2020 Feb; 138(2):182-188. PubMed ID: 31895446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed systemic recurrence of uveal melanoma.
    Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
    Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TYRP1 with hypoxia and its correlation with patient outcome in uveal melanoma.
    Jha J; Singh MK; Singh L; Pushker N; Lomi N; Meel R; Chosdol K; Sen S; Bakhshi S; Kashyap S
    Clin Transl Oncol; 2021 Sep; 23(9):1874-1884. PubMed ID: 33811629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.
    Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW
    JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
    Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
    Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.